Cargando…
A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis
Autores principales: | Twiddy, D, Naik, S, Mistry, R, Edwards, J, Walker, RA, Cohen, GM, MacFarlane, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875620/ http://dx.doi.org/10.1186/bcr2555 |
Ejemplares similares
-
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
por: Estornes, Yann, et al.
Publicado: (2018) -
Active Caspases and Cleaved Cytokeratins Are Sequestered into Cytoplasmic Inclusions in Trail-Induced Apoptosis
por: MacFarlane, Marion, et al.
Publicado: (2000) -
Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid
por: Ottewell, PD, et al.
Publicado: (2008) -
Effects of hypoxia and hypothermia on the end-inspiratory pause and Hering-Breüer reflex in the neonatal tammar wallaby
por: Frappell, PB, et al.
Publicado: (2001) -
Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis
por: Hague, A, et al.
Publicado: (2005)